Honestly, didn’t we all see this coming?
These Big Pharma cronies are some of the greediest people alive, and they’ll do anything to fatten their pockets.
With immunity from vaccine-related damages, these companies have free reign to push as many experimental/rushed jabs they want.
With the mainstream press and medical overlords still pumping COVID hysteria, millions of people are willing to line up for these jabs.
And Big Pharma is making a massive profit in the process:
Pfizer CFO said last month he saw “a significant opportunity for our vaccine from a demand perspective, from a pricing perspective, given the clinical profile of our vaccine.” Pfizer expecting $15b this year in vaccine sales, of which $4bn is profit: https://t.co/awd6jIxFs0
— Thomas Nash (@nashthomas) April 9, 2021
Unsurprisingly, Pfizer’s CEO stated that vaccine recipients would need a third COVID-19 shot 6-12 months after their 2nd dose.
And that regular booster shots would be needed every year.
So, they’re basically making COVID-19 the new influenza.
Does anyone know how effective influenza shots have been over the years?
Hint: not great.
It’s just another scam for Big Pharma to make billions in profits.
Pfizer CEO Albert Bourla says COVID vaccine recipients will "likely" need a third dose between 6-12 months after full vaccination followed by an annual shot.
"But all of that needs to be confirmed," he adds. pic.twitter.com/eCuxXNkOut
— The Recount (@therecount) April 15, 2021
Pfizer's chief executive says people will probably need a third dose of a Covid-19 vaccine within 12 months of being inoculated, and may require annual revaccination https://t.co/0RJUrlDyX5
— Financial Times (@FinancialTimes) April 16, 2021
Pfizer CEO says a third shot may be needed and then one every year.
I can hear the cash registers from here.
— Carl Vernon (@RealCarlVernon) April 15, 2021
NEW: People will "likely" need a third shot of the Pfizer vaccine as a booster within 12 months of being fully vaccinated, Pfizer CEO Albert Bourla told CNBC today. https://t.co/UqdQOB2UWU
— Axios (@axios) April 15, 2021
Pfizer CEO says you'll likely need a THIRD shot within the next 12 months.
Trust the Science?
— 🇺🇸 Matthew Holliday 🇺🇸 (@Matthew_4_Trump) April 15, 2021
The CEO of Pfizer compared COVID-19 shots to "vaccines like flu that you need every year.” https://t.co/XaihuXNiTl
— HuffPost (@HuffPost) April 16, 2021
Pfizer CEO Albert Bourla said people will “likely” need a booster dose of a Covid-19 vaccine within 12 months of getting fully vaccinated. His comments were made public Thursday but were taped April 1.
Bourla said it’s possible people will need to get vaccinated against the coronavirus annually.
“A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual revaccination, but all of that needs to be confirmed. And again, the variants will play a key role,” he told CNBC’s Bertha Coombs during an event with CVS Health.
“It is extremely important to suppress the pool of people that can be susceptible to the virus,” Bourla said.
The comment comes after Johnson & Johnson CEO Alex Gorsky told CNBC in February that people may need to get vaccinated against Covid-19 annually, just like seasonal flu shots.
Researchers still don’t know how long protection against the virus lasts once someone has been fully vaccinated.
Pfizer said earlier this month that its Covid-19 vaccine was more than 91% effective at protecting against the coronavirus and more than 95% effective against severe disease up to six months after the second dose. Moderna’s vaccine, which uses technology similar to Pfizer’s, was also shown to be highly effective at six months.
Pfizer’s data was based on more than 12,000 vaccinated participants. However, researchers say more data is still needed to determine whether protection lasts after six months.
Earlier Thursday, the Biden administration’s Covid response chief science officer, David Kessler, said Americans should expect to receive booster shots to protect against coronavirus variants.
Kessler told U.S. lawmakers that currently authorized vaccines are highly protective but noted new variants could “challenge” the effectiveness of the shots.